Results 1 to 10 of about 476,350 (261)
SARS‐CoV‐2 and hypertension [PDF]
Physiological Reports, 2021 The objective of this review is to give an overview of the pathophysiological effects of the Coronavirus Disease 2019 (COVID‐19) in relation to hypertension (HT), with a focus on the Renin–Angiotensin–Aldosterone System (RAAS) and the MAS receptor. HT is
Briyanth Ravichandran +5 more
doaj +4 more sources
Nature Reviews Microbiology, 2023 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence ...
Peter V Markov +2 more
exaly +3 more sources
SARS‐CoV‐2 and myasthenia [PDF]
Journal of Medical Virology, 2021 The COVID-19 pandemic due to infection with SARS-CoV-2 not only affects political, economic, social, and cultural life, but also has a significant impact on medicine. This article is protected by copyright. All rights reserved.
Finsterer, Josef +3 more
openaire +2 more sources
Epidemiology of SARS-CoV-2 [PDF]
Infection, 2020 Abstract Purpose SARS-CoV-2 is a recently emerged ß-coronavirus. Here we present the current knowledge on its epidemiologic features. Methods Non-systematic review.
Salzberger, Bernd +7 more
openaire +3 more sources
One Health, 2021 COVID-19 pandemic has challenged public health systems worldwide, particularly affecting developing countries in Latin America like Ecuador. In this report, we exposed the fundamental role of the Ecuadorian universities to improve COVID-19 surveillance ...
Daniela Santander-Gordon +19 more
doaj +1 more source
Cell Host & Microbe, 2021 A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss ...
Bogunovic, Dusan, Merad, Miriam
openaire +2 more sources
There is no “origin” to SARS-CoV-2
Environmental Research, 2022 Since the beginning of the COVID-19 pandemic in 2020 caused by SARS-CoV-2, the question of the origin of this virus has been a highly debated issue. Debates have been, and are still, very disputed and often violent between the two main hypotheses: a natural origin through the "spillover" model or a laboratory-leak origin.
Frutos, Roger +3 more
openaire +5 more sources
Frontiers in Microbiology, 2021 Since the emergence of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in December 2019, the scientific community has been sharing data on epidemiology, diagnostic methods, and whole-genomic sequences almost in real time. The latter have
Annika Brinkmann +9 more
doaj +1 more source
Scientific Reports, 2022 There is widespread concern about the clinical effectiveness of current vaccines in preventing Covid-19 caused by SARS-CoV-2 Variants of Concern (Williams in Lancet Respir Med 29:333–335, 2021; Hayawi in Vaccines 9:1305, 2021), including those identified
Spyros A. Charonis +2 more
doaj +1 more source
Scientific Reports, 2022 High-throughput detection of neutralizing antibodies against SARS-CoV-2 presents a valuable tool for vaccine trials or investigations of population immunity.
Natalie Hofmann +4 more
doaj +1 more source